World Health Organization Regional Assessments of the Risks of Poliovirus Outbreaks

While global polio eradication requires tremendous efforts in countries where wild polioviruses (WPVs) circulate, numerous outbreaks have occurred following WPV importation into previously polio-free countries. Countries that have interrupted endemic WPV transmission should continue to conduct routine risk assessments and implement mitigation activities to maintain their polio-free status as long as wild poliovirus circulates anywhere in the world. This article reviews the methods used by World Health Organization (WHO) regional offices to qualitatively assess risk of WPV outbreaks following an importation. We describe the strengths and weaknesses of various risk assessment approaches, and opportunities to harmonize approaches. These qualitative assessments broadly categorize risk as high, medium, or low using available national information related to susceptibility, the ability to rapidly detect WPV, and other population or program factors that influence transmission, which the regions characterize using polio vaccination coverage, surveillance data, and other indicators (e.g., sanitation), respectively. Data quality and adequacy represent a challenge in all regions. WHO regions differ with respect to the methods, processes, cut-off values, and weighting used, which limits comparisons of risk assessment results among regions. Ongoing evaluation of indicators within regions and further harmonization of methods between regions are needed to effectively plan risk mitigation activities in a setting of finite resources for funding and continued WPV circulation.

[1]  Rouslan Karimov,et al.  WHO and UNICEF estimates of national infant immunization coverage: methods and processes. , 2009, Bulletin of the World Health Organization.

[2]  L. Pritchett,et al.  The impact of public spending on health: does money matter? , 1999, Social science & medicine.

[3]  N. Grassly,et al.  A Statistical Model of the International Spread of Wild Poliovirus in Africa Used to Predict and Prevent Outbreaks , 2011, PLoS medicine.

[4]  M. Pallansch,et al.  Preeradication Vaccine Policy Options for Poliovirus Infection and Disease Control , 2013, Risk analysis : an official publication of the Society for Risk Analysis.

[5]  C. Murray,et al.  Validity of reported vaccination coverage in 45 countries , 2003, The Lancet.

[6]  J. Lloyd,et al.  The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems. , 2005, Bulletin of the World Health Organization.

[7]  K. Cantell,et al.  OUTBREAK OF PARALYTIC POLIOMYELITIS IN FINLAND: WIDESPREAD CIRCULATION OF ANTIGENICALLY ALTERED POLIOVIRUS TYPE 3 IN A VACCINATED POPULATION , 1986, The Lancet.

[8]  A. Calder,et al.  Letter: Prostaglandins and the unfavourable cervix. , 1973, Lancet.

[9]  Kimberly M Thompson,et al.  The risks, costs, and benefits of possible future global policies for managing polioviruses. , 2008, American journal of public health.

[10]  P. Keefer,et al.  Democracy, Public Expenditures, and the Poor: Understanding Political Incentives for Providing Public Services , 2005 .

[11]  J. Hammer,et al.  Weak Links in the Chain , 2000 .

[12]  C. Vermylen,et al.  BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIA , 1988, The Lancet.

[13]  F. Castro-Leal,et al.  Public social spending in Africa : do the poor benefit? , 1999 .

[14]  J. Deshpande,et al.  Environmental Surveillance System To Track Wild Poliovirus Transmission , 2003, Applied and Environmental Microbiology.

[15]  Stephen S Lim,et al.  Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage , 2008, The Lancet.

[16]  L. Schonberger,et al.  OUTBREAK OF PARALYTIC POLIOMYELITIS, TAIWAN , 1984, The Lancet.

[17]  Klaudia Porten,et al.  Poliomyelitis Outbreak,Pointe-Noire, Republic of the Congo, September 2010–February 2011 , 2011, Emerging infectious diseases.

[18]  R. D. Tebbens,et al.  Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses , 2013, Risk analysis : an official publication of the Society for Risk Analysis.

[19]  N. Nathanson,et al.  From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed , 2010, American journal of epidemiology.

[20]  R. Leke,et al.  Certification of polio eradication: process and lessons learned. , 2004, Bulletin of the World Health Organization.